Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

View all journals
Search
Log in

nature
search

Search

Advanced search

Filter By:

Journal Check one or more journals to show results from those journals only.

Scientific Reports (2)
Nature Communications (1)
Nature Genetics (1)

Choose more journals

Article type Check one or more article types to show results from those article types only.

Research (4)

Subject Check one or more subjects to show results from those subjects only.

Cancer
Medical research
Molecular medicine
Risk factors

Date Choose a date option to show results from those dates only.

Today
Last 7 days
Last 30 days
Last 12 months
Last 2 years
Last 5 years

Custom date range

Clear all filters

Sort by:

Relevance

Date published (new to old)

Date published (old to new)

Showing 1–4 of 4 results

Advanced filters: Author: Ping Teresa Yeh Clear advanced filters

Germline modifiers of the tumor immune microenvironment implicate drivers of cancer risk and immunotherapy response

The contribution of genetic factors to the tumour immune microenvironment (TIME) remains to be investigated. Here, the authors suggest the role of TIME eQTLs for target genes involved in reversing immune suppressive features.

Meghana Pagadala
Timothy J. Sears
Hannah Carter
ResearchOpen Access12 May 2023
Nature Communications

Volume: 14, P: 1-22
Trends in mobile phone ownership, frequency of number changes, and implications for public health service delivery in Uganda, 2010–2020

Robert Ssekubugu
Ping Teresa Yeh
Helena Nordenstedt
ResearchOpen Access11 Jul 2025
Scientific Reports

Volume: 15, P: 1-13
Variants in the CDKN2B and RTEL1 regions are associated with high-grade glioma susceptibility

Margaret Wrensch and colleagues report a genome-wide association and replication study for high-grade glioma. They show that common variants in the CDKN2B and RTEL1 regions are associated with risk of this aggressive brain tumor.

Margaret Wrensch
Robert B Jenkins
John K Wiencke
Research05 Jul 2009
Nature Genetics

Volume: 41, P: 905-908
A Phase II Study of Arginine Deiminase (ADI-PEG20) in Relapsed/Refractory or Poor-Risk Acute Myeloid Leukemia Patients

Hui-Jen Tsai
Shih Sheng Jiang
Tsai-Yun Chen
ResearchOpen Access12 Sept 2017
Scientific Reports

Volume: 7, P: 1-10